BMY
Bristol-Myers Squibb Company
61.50$
-1.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.8% | 12.7% | 15.7% | 25.4% | 31.3% | 30.9% | 33.0% | 34.9% | 28.3% | 30.8% | 31.4% | 29.4% | |
| 2.9% | 2.3% | 2.0% | 3.8% | 2.8% | 6.7% | 24.4% | 23.0% | 22.3% | 21.7% | 19.9% | 8.3% | |
| 1.3% | 1.4% | 1.1% | 1.0% | 1.0% | 1.7% | 1.8% | 1.3% | 1.0% | 1.2% | 1.0% | 1.1% | |
| -3.3% | 3.7% | 0.3% | 7.9% | 4.0% | -0.2% | -0.5% | -1.6% | -2.3% | – | – | – | |
| 1.5% | -4.4% | -5.9% | 10.3% | 1.0% | 11.7% | 2.3% | -2.7% | -4.8% | -4.3% | 1.7% | -0.9% | |
| 3.3% | 5.0% | 6.3% | 5.1% | 4.2% | 3.2% | 1.8% | 2.1% | 2.4% | 2.7% | 2.6% | 2.7% | |
| 7.7% | -9.5% | 7.6% | -0.3% | -8.9% | -37.4% | -25.5% | -1.2% | -2.3% | -5.1% | -44.2% | -8.6% | |
| 15.1% | 15.0% | 13.1% | 12.4% | 11.6% | 10.2% | 9.6% | 9.5% | 10.0% | 10.5% | 10.1% | 10.5% | |
| 1.5% | 4.9% | -1.2% | -11.9% | -1.4% | -27.9% | -3.6% | -13.6% | -17.3% | -11.5% | 0.0% | 0.0% | |
| -2.1% | -6.9% | 0.6% | 4.8% | -2.4% | 67.5% | 9.2% | -13.3% | -11.5% | 1.0% | 20.9% | -10.7% | |
| -15.3% | -21.9% | -13.7% | -19.6% | -15.7% | 29.1% | -2.7% | -35.0% | -36.7% | -20.9% | 10.6% | -21.5% | |
| 12.5% | -19.2% | 9.5% | 5.7% | 6.6% | 22.6% | 5.1% | -1.4% | -10.8% | 4.9% | -2.4% | -0.3% | |
| 16.5% | 7.8% | 9.5% | 20.3% | 27.1% | 27.7% | 31.3% | 32.8% | 25.9% | 28.1% | 28.9% | 26.7% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.